» Authors » Junichi Kaburaki

Junichi Kaburaki

Explore the profile of Junichi Kaburaki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 186
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Kumagai S, Kawano S, Atsumi T, Inokuma S, Okada Y, Kanai Y, et al.
J Rheumatol . 2005 May; 32(5):863-9. PMID: 15868623
Objective: To evaluate the factors influencing the occurrence of vertebral fracture in patients receiving high dose glucocorticoids (GC). Methods: A cross-sectional study was performed on women who had received at...
12.
Kuwana M, Matsuura E, Kobayashi K, Okazaki Y, Kaburaki J, Ikeda Y, et al.
Blood . 2004 Oct; 105(4):1552-7. PMID: 15486070
Antiphospholipid syndrome (APS) is an autoimmune prothrombotic disorder in association with autoantibodies to phospholipid (PL)-binding plasma proteins, such as beta(2)-glycoprotein I (beta(2)GPI). We have recently found that CD4(+) T cells...
13.
Kuwana M, Pandey J, Silver R, Kawakami Y, Kaburaki J
J Rheumatol . 2003 Dec; 30(11):2392-7. PMID: 14677183
Objective: To examine HLA class II gene associations with anti-RNA polymerase (RNAP) I/III antibody responses in patients with systemic sclerosis (SSc). Methods: HLA-DRB1, DRB3, DRB4, and DQB1 alleles were determined...
14.
Kaburaki J
Nihon Naika Gakkai Zasshi . 2003 Nov; 92(10):1963-8. PMID: 14621586
No abstract available.
15.
Kaburaki J, Kuwana M, Ikeda Y
Rinsho Byori . 2003 Aug; 51(7):639-43. PMID: 12924247
The concept of antiphospholipid syndrome(APS) has been widely accepted. Antiphospholipid antibodies originally included anticardiolipin antibodies and lupus anticoagulants as serological marker of APS. However, recent advances have shown that most...
16.
Kuwana M, Okazaki Y, Kaburaki J, Ikeda Y
Am J Med . 2003 Apr; 114(4):322-5. PMID: 12681462
No abstract available.
17.
Kaburaki J, Kuwana M, Ikeda Y
Rinsho Ketsueki . 2003 Mar; 44(1):28-30. PMID: 12649835
In this study, we clarified the clinical significance of IgG anti-phosphatidylserine-prothrombin complex (PS-PT) antibodies in the diagnosis of antiphospholipid syndrome (APS). The study population consisted of 113 patients with SLE...
18.
Kuwana M, Okazaki Y, Kajihara M, Kaburaki J, Miyazaki H, Kawakami Y, et al.
Arthritis Rheum . 2002 Sep; 46(8):2148-59. PMID: 12209520
Objective: To examine the prevalence, clinical associations, and pathogenic role of autoantibodies to c-Mpl, the thrombopoietin (TPO) receptor, in patients with systemic lupus erythematosus (SLE). Methods: Sera from 69 SLE...
19.
Kuwana M, Okazaki Y, Kaburaki J, Kawakami Y, Ikeda Y
J Immunol . 2002 Mar; 168(7):3675-82. PMID: 11907134
We have recently reported that in patients with chronic immune thrombocytopenic purpura (IMTP), circulating T and B cells that are responsive to gpIIb-IIIa can induce anti-platelet autoantibody production. In this...
20.
Yoshida K, Arai T, Kaburaki J, Ikeda Y, Kawakami Y, Kuwana M
Blood . 2002 Mar; 99(7):2499-504. PMID: 11895785
We recently identified CD4(+) T cells that are autoreactive to beta(2)-glycoprotein I (beta(2)GPI) and that promote antiphospholipid antibody production in patients with antiphospholipid syndrome (APS). In this study, T-cell receptor...